CDNA:CA:TSX-CI Bio-Revolution Index ETF (CAD)

ETF | Others |

Last Closing

CAD 17.3

Change

-0.21 (-1.20)%

Market Cap

CAD 6.10M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

ETFs Containing CDNA:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.14% 6% D- 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.14% 7% C- 16% F
Trailing 12 Months  
Capital Gain 8.13% 24% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.13% 23% F 25% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -4.79% N/A N/A 12% F
Dividend Return -4.79% N/A N/A 10% F
Total Return 0.00% N/A N/A 1% F
Risk Return Profile  
Volatility (Standard Deviation) 7.24% N/A N/A 88% B+
Risk Adjusted Return -66.11% N/A N/A 4% F
Market Capitalization 6.10M 17% F 6% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.